iMM-CARE Strategic R&I Agenda

The iMM-CARE SRIA will be the result of a quadruple-helix co-creation process with the most important stakeholders in health R&I: citizens and patients, scientists and clinicians, policy-makers and health authorities, and business executives and investors. The SRIA will be available at M1, updated in M36 and M72.